Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Jeannette Lee

Concepts (464)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
20
2023
357
3.060
 Why?
Anus Neoplasms
10
2023
24
2.220
 Why?
Stroke
7
2024
493
1.870
 Why?
Acquired Immunodeficiency Syndrome
11
2022
54
1.670
 Why?
Prostatic Hyperplasia
10
2015
39
1.510
 Why?
Brain
9
2024
1328
1.450
 Why?
Parkinson Disease
2
2023
151
1.320
 Why?
Randomized Controlled Trials as Topic
8
2024
550
1.290
 Why?
Chlamydia Infections
8
2017
77
1.260
 Why?
Sarcoma, Kaposi
12
2022
72
1.100
 Why?
Papillomavirus Infections
5
2022
155
1.070
 Why?
Chlamydia trachomatis
6
2017
30
1.060
 Why?
Lymphoma, AIDS-Related
10
2020
16
1.030
 Why?
Plant Extracts
5
2013
171
0.950
 Why?
Brain Ischemia
2
2023
161
0.940
 Why?
Mesenchymal Stem Cell Transplantation
1
2024
18
0.940
 Why?
Serenoa
5
2013
7
0.900
 Why?
Humans
101
2024
50208
0.890
 Why?
Phytotherapy
3
2012
43
0.830
 Why?
Rural Population
4
2023
537
0.830
 Why?
Umbilical Cord
2
2020
35
0.820
 Why?
Lymphoma, Non-Hodgkin
6
2021
59
0.750
 Why?
Antineoplastic Combined Chemotherapy Protocols
12
2021
990
0.750
 Why?
Middle Aged
50
2021
12206
0.740
 Why?
Research Design
5
2022
342
0.720
 Why?
Male
61
2024
25399
0.690
 Why?
Neonatal Abstinence Syndrome
3
2024
25
0.680
 Why?
Rats
9
2024
3299
0.680
 Why?
Fetal Blood
2
2019
69
0.680
 Why?
Adult
48
2022
13324
0.660
 Why?
Infarction, Middle Cerebral Artery
4
2024
40
0.660
 Why?
Inflammation
3
2021
604
0.650
 Why?
Patient Participation
1
2018
66
0.610
 Why?
Vaginosis, Bacterial
2
2015
8
0.580
 Why?
Decision Making
1
2018
267
0.540
 Why?
Mammography
1
2016
94
0.530
 Why?
Neoplasms
3
2023
1249
0.530
 Why?
Female
48
2024
26635
0.520
 Why?
Antineoplastic Agents
9
2023
1186
0.510
 Why?
Aged
28
2020
9405
0.500
 Why?
Antibodies, Monoclonal, Murine-Derived
6
2015
47
0.500
 Why?
Population Density
1
2014
15
0.490
 Why?
Pelvic Inflammatory Disease
2
2018
8
0.480
 Why?
AIDS-Related Opportunistic Infections
5
2016
40
0.480
 Why?
Carcinoma in Situ
3
2013
72
0.460
 Why?
Animals
15
2024
13246
0.460
 Why?
Rats, Sprague-Dawley
7
2024
1586
0.460
 Why?
Cytokines
5
2023
613
0.460
 Why?
Anti-Bacterial Agents
5
2020
747
0.450
 Why?
Uterine Cervicitis
1
2013
3
0.440
 Why?
Hydrocephalus, Normal Pressure
1
2012
1
0.430
 Why?
Urethritis
2
2012
5
0.430
 Why?
Finasteride
4
2015
4
0.420
 Why?
Stem Cell Transplantation
3
2024
182
0.420
 Why?
Lymphoma, Large B-Cell, Diffuse
3
2021
106
0.410
 Why?
Research Subjects
1
2013
49
0.410
 Why?
Guideline Adherence
1
2013
133
0.410
 Why?
Subarachnoid Hemorrhage
1
2012
65
0.400
 Why?
Breast Neoplasms
3
2017
1179
0.400
 Why?
Patient Dropouts
1
2012
53
0.400
 Why?
Carcinoma, Non-Small-Cell Lung
1
2013
154
0.390
 Why?
Urologic Diseases
1
2011
10
0.390
 Why?
Analgesics, Opioid
4
2024
557
0.380
 Why?
HIV-1
6
2020
55
0.380
 Why?
Lung Neoplasms
2
2013
605
0.370
 Why?
Disease Models, Animal
5
2024
1458
0.350
 Why?
United States
10
2023
4874
0.350
 Why?
Young Adult
16
2018
3981
0.340
 Why?
Patient Selection
1
2011
253
0.340
 Why?
Asthma
2
2024
280
0.340
 Why?
Quality of Life
6
2024
839
0.340
 Why?
Lymphedema
2
2022
43
0.340
 Why?
HIV Seropositivity
3
2021
27
0.330
 Why?
Lower Urinary Tract Symptoms
3
2013
6
0.330
 Why?
Intestinal Mucosa
2
2021
215
0.330
 Why?
Polymorphism, Single Nucleotide
3
2017
485
0.310
 Why?
Gonorrhea
2
2020
9
0.310
 Why?
Azithromycin
4
2020
25
0.300
 Why?
Stem Cells
2
2019
171
0.300
 Why?
Risk Factors
8
2022
3629
0.290
 Why?
Th1 Cells
2
2017
52
0.290
 Why?
Vascular Endothelial Growth Factor A
4
2017
202
0.270
 Why?
Treatment Outcome
17
2020
5155
0.270
 Why?
Mycoplasma genitalium
2
2018
2
0.260
 Why?
Doxazosin
3
2015
3
0.260
 Why?
Mycoplasma Infections
2
2018
7
0.260
 Why?
Anti-Infective Agents
2
2020
95
0.260
 Why?
Prospective Studies
11
2022
2379
0.260
 Why?
Doxycycline
3
2015
33
0.260
 Why?
Cyclophosphamide
9
2021
166
0.260
 Why?
Cancer Vaccines
1
2006
78
0.260
 Why?
Vincristine
8
2021
88
0.250
 Why?
Multicenter Studies as Topic
4
2024
88
0.250
 Why?
Hematopoietic Stem Cell Transplantation
3
2018
567
0.240
 Why?
Adolescent
13
2022
6390
0.240
 Why?
Air Filters
1
2024
1
0.240
 Why?
Double-Blind Method
4
2013
688
0.240
 Why?
Thymus Gland
2
2021
41
0.230
 Why?
Air Pollution, Indoor
1
2024
25
0.230
 Why?
CD4 Lymphocyte Count
7
2020
32
0.230
 Why?
Bronchiolitis
1
2024
27
0.230
 Why?
Prevalence
6
2021
951
0.230
 Why?
5-alpha Reductase Inhibitors
2
2015
3
0.230
 Why?
Hyperbaric Oxygenation
1
2023
13
0.230
 Why?
Homosexuality, Male
3
2022
51
0.230
 Why?
Substantia Nigra
1
2023
14
0.220
 Why?
alpha-Synuclein
1
2023
10
0.220
 Why?
Doxorubicin
8
2021
239
0.220
 Why?
Transplantation Conditioning
2
2018
84
0.220
 Why?
Nervous System Diseases
1
2024
89
0.220
 Why?
Informatics
1
2023
8
0.220
 Why?
Tumor Necrosis Factor-alpha
2
2017
388
0.220
 Why?
Herpesvirus 8, Human
5
2020
91
0.220
 Why?
Prednisone
7
2021
101
0.220
 Why?
Cross-Sectional Studies
3
2021
1554
0.210
 Why?
Follow-Up Studies
8
2019
2190
0.210
 Why?
Brachytherapy
1
2022
48
0.210
 Why?
Astrocytes
1
2024
146
0.210
 Why?
Child
8
2024
6851
0.210
 Why?
Watchful Waiting
1
2022
27
0.210
 Why?
Feasibility Studies
2
2021
380
0.210
 Why?
Medical Records
1
2022
83
0.210
 Why?
Absorptiometry, Photon
1
2003
153
0.200
 Why?
Substance Withdrawal Syndrome
1
2023
171
0.200
 Why?
Vitamin D Deficiency
1
2022
44
0.200
 Why?
Genome-Wide Association Study
3
2018
166
0.200
 Why?
Viral Load
6
2020
77
0.200
 Why?
Brain Injuries
1
2023
157
0.200
 Why?
Case-Control Studies
3
2014
1126
0.200
 Why?
Vaccines
1
2022
50
0.200
 Why?
Precancerous Conditions
1
2022
83
0.200
 Why?
Mouth Diseases
1
2021
5
0.200
 Why?
Vaccination
3
2022
271
0.200
 Why?
Clinical Trials as Topic
5
2020
466
0.200
 Why?
Lymphocyte Activation
3
2017
172
0.190
 Why?
Papillomaviridae
2
2016
102
0.190
 Why?
Mass Screening
2
2015
346
0.190
 Why?
Neoplasm Staging
4
2022
738
0.190
 Why?
Pluripotent Stem Cells
1
2021
6
0.190
 Why?
Physical Conditioning, Animal
1
2021
52
0.190
 Why?
Primary Health Care
2
2022
360
0.190
 Why?
Drug Therapy, Combination
5
2015
381
0.190
 Why?
T-Lymphocyte Subsets
2
2017
39
0.190
 Why?
Papillomavirus Vaccines
2
2013
61
0.180
 Why?
Vagina
2
2018
45
0.180
 Why?
Etoposide
5
2021
72
0.180
 Why?
Anti-HIV Agents
3
2020
42
0.180
 Why?
Cross-Over Studies
1
2021
218
0.180
 Why?
Spleen
1
2021
172
0.180
 Why?
Enzyme Inhibitors
2
2016
386
0.180
 Why?
Genes, myc
1
2020
41
0.180
 Why?
Gene Frequency
2
2017
94
0.180
 Why?
Overweight
1
2022
217
0.180
 Why?
Transplantation, Autologous
3
2018
469
0.180
 Why?
Aged, 80 and over
5
2013
3154
0.170
 Why?
Cell Differentiation
2
2021
650
0.170
 Why?
Uterine Cervical Neoplasms
1
2022
276
0.170
 Why?
Dihydroxyphenylalanine
1
2019
5
0.170
 Why?
Dopaminergic Neurons
1
2019
18
0.170
 Why?
Empathy
1
2019
46
0.170
 Why?
Ablation Techniques
1
2019
21
0.170
 Why?
Infant, Newborn
5
2024
2766
0.160
 Why?
Social Environment
1
2019
79
0.160
 Why?
Altruism
1
2018
13
0.160
 Why?
Central Nervous System Diseases
1
2019
27
0.160
 Why?
Sodium, Dietary
1
2019
26
0.160
 Why?
Mitochondria
2
2020
404
0.160
 Why?
Asymptomatic Infections
1
2018
6
0.160
 Why?
Dopamine
1
2019
172
0.160
 Why?
Antiviral Agents
2
2013
173
0.160
 Why?
Acoustic Stimulation
1
2018
97
0.160
 Why?
Sexually Transmitted Diseases
1
2018
36
0.160
 Why?
Enzyme-Linked Immunosorbent Assay
3
2017
244
0.150
 Why?
Energy Metabolism
1
2020
279
0.150
 Why?
Hyperthermia, Induced
1
2019
117
0.150
 Why?
Chlamydia
1
2017
8
0.150
 Why?
Protein Kinase Inhibitors
2
2023
206
0.150
 Why?
Mucous Membrane
1
2017
28
0.150
 Why?
Blood Cells
1
2017
43
0.150
 Why?
Pilot Projects
3
2019
697
0.150
 Why?
Biopsy
2
2022
590
0.150
 Why?
Genetic Predisposition to Disease
2
2018
509
0.150
 Why?
Clostridium Infections
1
2018
53
0.150
 Why?
DNA, Circular
1
2017
18
0.150
 Why?
Antibodies, Bacterial
1
2017
28
0.150
 Why?
Clonal Evolution
1
2017
56
0.140
 Why?
Immunoglobulins
1
2017
79
0.140
 Why?
Immunoglobulin G
1
2017
186
0.140
 Why?
Telemedicine
1
2022
449
0.140
 Why?
Anus Diseases
1
2016
2
0.140
 Why?
Sentinel Lymph Node Biopsy
1
2017
117
0.140
 Why?
Mannitol
1
2016
15
0.130
 Why?
Lymph Node Excision
1
2017
137
0.130
 Why?
Thiazoles
1
2016
53
0.130
 Why?
Adrenergic alpha-1 Receptor Antagonists
1
2015
8
0.130
 Why?
Guidelines as Topic
1
2016
111
0.130
 Why?
Diagnostic Self Evaluation
1
2015
14
0.130
 Why?
Comorbidity
2
2018
613
0.130
 Why?
Blood-Brain Barrier
1
2016
48
0.130
 Why?
Anal Canal
3
2023
21
0.130
 Why?
Educational Status
1
2016
223
0.130
 Why?
CD4-Positive T-Lymphocytes
1
2017
164
0.130
 Why?
Tinidazole
2
2012
2
0.130
 Why?
Dose-Response Relationship, Drug
4
2013
1378
0.130
 Why?
T-Lymphocytes
1
2017
339
0.130
 Why?
Imidazoles
1
2016
128
0.130
 Why?
Burkitt Lymphoma
1
2015
28
0.130
 Why?
Drug Administration Schedule
5
2020
377
0.120
 Why?
Lymph Nodes
1
2017
263
0.120
 Why?
Menarche
1
2014
7
0.120
 Why?
Data Collection
3
2023
277
0.120
 Why?
Stomatitis
1
2014
16
0.120
 Why?
Chromosomes, Human, Pair 2
1
2014
25
0.120
 Why?
Obesity
3
2022
1108
0.120
 Why?
Immunophenotyping
2
2017
109
0.120
 Why?
Disease-Free Survival
5
2016
454
0.120
 Why?
Hypogonadism
1
2013
10
0.110
 Why?
Benzamides
1
2013
51
0.110
 Why?
Carcinoma, Squamous Cell
1
2016
318
0.110
 Why?
Incidence
4
2018
1006
0.110
 Why?
Stress Disorders, Post-Traumatic
1
2018
365
0.110
 Why?
SEER Program
1
2013
92
0.110
 Why?
Health Surveys
1
2014
232
0.110
 Why?
Urban Population
1
2014
150
0.110
 Why?
Heart Failure
1
2019
506
0.110
 Why?
Organophosphonates
1
2013
7
0.110
 Why?
Testosterone
1
2013
140
0.110
 Why?
Perineum
1
2013
24
0.110
 Why?
Stress, Psychological
2
2019
261
0.110
 Why?
DNA, Viral
3
2020
134
0.110
 Why?
Placebos
1
2013
86
0.110
 Why?
Cytosine
1
2013
30
0.110
 Why?
Adrenergic alpha-Antagonists
2
2009
27
0.110
 Why?
tau Proteins
1
2012
26
0.110
 Why?
Piperazines
1
2013
118
0.110
 Why?
Prostate
2
2015
117
0.110
 Why?
HIV
3
2023
24
0.110
 Why?
Trichomonas Infections
1
2012
2
0.100
 Why?
Trichomonas vaginalis
1
2012
3
0.100
 Why?
Transforming Growth Factor beta1
1
2012
60
0.100
 Why?
Sleep
2
2024
184
0.100
 Why?
Pyrimidines
1
2013
193
0.100
 Why?
Vulvar Neoplasms
1
2013
52
0.100
 Why?
Time Factors
5
2023
2922
0.100
 Why?
Medicare
1
2013
249
0.100
 Why?
Androgen Antagonists
1
2011
11
0.100
 Why?
Urination Disorders
1
2011
23
0.100
 Why?
Sirolimus
1
2012
62
0.100
 Why?
Antibiotics, Antineoplastic
1
2012
81
0.100
 Why?
Kenya
2
2022
10
0.100
 Why?
CD8-Positive T-Lymphocytes
2
2017
128
0.100
 Why?
Quinazolinones
1
2011
6
0.090
 Why?
Human papillomavirus 16
2
2013
44
0.090
 Why?
Practice Guidelines as Topic
1
2013
449
0.090
 Why?
Arkansas
1
2016
1985
0.090
 Why?
Social Class
1
2011
93
0.090
 Why?
Prognosis
5
2017
1954
0.090
 Why?
Multivariate Analysis
1
2012
581
0.090
 Why?
Methotrexate
2
2015
69
0.090
 Why?
Chronic Disease
1
2012
571
0.090
 Why?
Piperidines
1
2011
98
0.090
 Why?
Plant Bark
1
2009
6
0.090
 Why?
Colorectal Neoplasms
1
2013
236
0.090
 Why?
Valproic Acid
1
2009
32
0.090
 Why?
Multiple Myeloma
2
2014
2954
0.090
 Why?
Socioeconomic Factors
1
2012
579
0.080
 Why?
Ki-67 Antigen
1
2009
57
0.080
 Why?
India
2
2021
51
0.080
 Why?
Logistic Models
1
2012
889
0.080
 Why?
Fruit
1
2009
112
0.080
 Why?
Tetracyclines
2
2006
7
0.080
 Why?
Neoplasm Recurrence, Local
1
2012
613
0.080
 Why?
Cisplatin
2
2022
278
0.080
 Why?
Antiretroviral Therapy, Highly Active
3
2015
34
0.080
 Why?
Glomerulonephritis, IGA
1
2007
5
0.080
 Why?
Survival Analysis
3
2017
666
0.080
 Why?
Galactose
1
2007
28
0.080
 Why?
Immunoglobulin A
1
2007
45
0.070
 Why?
Adaptive Immunity
2
2017
32
0.070
 Why?
Glioblastoma
1
2009
93
0.070
 Why?
Sexual Partners
2
2018
29
0.070
 Why?
Disease Progression
4
2013
831
0.070
 Why?
Regression Analysis
2
2018
395
0.070
 Why?
Chaperonins
1
2006
3
0.070
 Why?
Chaperonin 60
1
2006
5
0.070
 Why?
Dose-Response Relationship, Immunologic
1
2006
13
0.070
 Why?
Lymphocyte Count
1
2006
22
0.070
 Why?
Papillomavirus E7 Proteins
1
2006
31
0.070
 Why?
Viral Vaccines
1
2006
12
0.070
 Why?
Sexual Behavior
2
2018
117
0.070
 Why?
HIV Protease Inhibitors
1
2006
2
0.070
 Why?
Immunohistochemistry
3
2017
978
0.070
 Why?
Interferon-alpha
1
2006
48
0.070
 Why?
Infant
2
2024
3563
0.070
 Why?
Nephrosis, Lipoid
1
2005
5
0.070
 Why?
Arterioles
1
2005
33
0.060
 Why?
Severity of Illness Index
2
2023
951
0.060
 Why?
Body Mass Index
2
2022
656
0.060
 Why?
Brain Neoplasms
1
2009
288
0.060
 Why?
Recombinant Fusion Proteins
1
2006
186
0.060
 Why?
Matrix Metalloproteinase 9
3
2017
89
0.060
 Why?
Administration, Oral
4
2013
434
0.060
 Why?
Aminoimidazole Carboxamide
1
2004
3
0.060
 Why?
Administration, Intranasal
1
2024
29
0.060
 Why?
Phenotype
2
2017
733
0.060
 Why?
Leucovorin
1
2004
20
0.060
 Why?
Purines
1
2004
38
0.060
 Why?
Genotype
2
2017
534
0.060
 Why?
Neutropenia
2
2020
115
0.060
 Why?
Confidence Intervals
2
2015
156
0.060
 Why?
Dust
1
2024
22
0.060
 Why?
Particulate Matter
1
2024
52
0.060
 Why?
Arthritis, Rheumatoid
1
2004
105
0.060
 Why?
Carbon
1
2024
54
0.060
 Why?
Folic Acid
1
2004
137
0.060
 Why?
Cytochrome P-450 CYP3A
1
2023
78
0.060
 Why?
Femur Neck
1
2003
6
0.050
 Why?
Africa South of the Sahara
1
2022
5
0.050
 Why?
Hip
1
2003
25
0.050
 Why?
Drug Delivery Systems
1
2024
146
0.050
 Why?
Quality Control
1
2003
92
0.050
 Why?
Bacterial Proteins
1
2006
376
0.050
 Why?
Narcotics
1
2023
111
0.050
 Why?
Sample Size
1
2022
37
0.050
 Why?
Eating
1
2023
161
0.050
 Why?
Breast Feeding
1
2024
188
0.050
 Why?
Vitamins
1
2022
64
0.050
 Why?
Femur
1
2003
133
0.050
 Why?
Spine
1
2003
94
0.050
 Why?
Matrix Metalloproteinase Inhibitors
1
2002
10
0.050
 Why?
Tetracycline
1
2002
20
0.050
 Why?
Radiotherapy Dosage
1
2022
246
0.050
 Why?
Vitamin D
1
2022
88
0.050
 Why?
Tretinoin
1
2002
53
0.050
 Why?
Leg
1
2022
122
0.050
 Why?
Fibroblast Growth Factor 2
2
2017
34
0.050
 Why?
Antibodies, Monoclonal
1
2005
460
0.050
 Why?
Museums
1
2021
2
0.050
 Why?
Regenerative Medicine
1
2021
9
0.050
 Why?
Alprostadil
1
2021
10
0.050
 Why?
Kidney
1
2005
672
0.050
 Why?
Length of Stay
1
2024
621
0.050
 Why?
Oxygen
1
2023
325
0.050
 Why?
Zimbabwe
1
2020
2
0.050
 Why?
Malawi
1
2020
10
0.050
 Why?
Wharton Jelly
1
2020
1
0.050
 Why?
Uganda
1
2020
36
0.050
 Why?
Herpesvirus 4, Human
1
2020
35
0.050
 Why?
Body Composition
1
2003
319
0.050
 Why?
Cell Shape
1
2020
20
0.050
 Why?
Software
1
2003
271
0.050
 Why?
Neisseria gonorrhoeae
1
2020
4
0.040
 Why?
Herpesviridae Infections
1
2020
46
0.040
 Why?
Ceftriaxone
1
2020
26
0.040
 Why?
Histone Deacetylase Inhibitors
1
2020
56
0.040
 Why?
B-Lymphocytes
1
2021
170
0.040
 Why?
Drug Resistance, Bacterial
1
2020
71
0.040
 Why?
Thrombocytopenia
1
2020
84
0.040
 Why?
Cohort Studies
2
2018
1422
0.040
 Why?
Remission Induction
2
2012
207
0.040
 Why?
Proctoscopy
1
2019
2
0.040
 Why?
Interleukin-6
2
2016
265
0.040
 Why?
Kaplan-Meier Estimate
1
2020
465
0.040
 Why?
Microbial Sensitivity Tests
1
2020
270
0.040
 Why?
Cell Survival
1
2020
602
0.040
 Why?
Masks
1
2018
30
0.040
 Why?
Statistics, Nonparametric
2
2013
193
0.040
 Why?
Receptors, Chemokine
1
2017
12
0.040
 Why?
Models, Animal
1
2019
232
0.040
 Why?
Coinfection
1
2018
38
0.040
 Why?
Neurodegenerative Diseases
1
2019
78
0.040
 Why?
Pandemics
1
2022
562
0.040
 Why?
Bone Marrow
1
2019
363
0.040
 Why?
Neurogenesis
1
2017
27
0.040
 Why?
Cell Separation
1
2017
90
0.040
 Why?
Cytological Techniques
1
2017
14
0.040
 Why?
Angiopoietin-2
1
2017
15
0.040
 Why?
Angiopoietin-1
1
2017
16
0.040
 Why?
Interleukin-2
1
2017
72
0.040
 Why?
Receptor, TIE-2
1
2017
16
0.040
 Why?
Axilla
1
2017
90
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2017
44
0.040
 Why?
Fluorouracil
1
2016
54
0.040
 Why?
Staining and Labeling
1
2017
97
0.040
 Why?
Gene Rearrangement
1
2017
74
0.030
 Why?
Biopsy, Needle
1
2017
181
0.030
 Why?
Odds Ratio
1
2018
546
0.030
 Why?
Neuroprotective Agents
1
2017
103
0.030
 Why?
Chemoradiotherapy
1
2016
40
0.030
 Why?
Membrane Glycoproteins
1
2017
246
0.030
 Why?
Interferon-gamma
1
2017
176
0.030
 Why?
Cord Blood Stem Cell Transplantation
1
2016
5
0.030
 Why?
Mastectomy
1
2017
141
0.030
 Why?
Directly Observed Therapy
1
2015
8
0.030
 Why?
Urine
1
2015
23
0.030
 Why?
Reagent Kits, Diagnostic
1
2015
18
0.030
 Why?
Vaginal Smears
1
2015
27
0.030
 Why?
RNA, Viral
2
2009
126
0.030
 Why?
Neoadjuvant Therapy
1
2017
117
0.030
 Why?
Neovascularization, Pathologic
1
2017
162
0.030
 Why?
Treatment Failure
1
2015
116
0.030
 Why?
Prisons
1
2015
38
0.030
 Why?
Ifosfamide
1
2015
9
0.030
 Why?
Cytarabine
1
2015
39
0.030
 Why?
Flow Cytometry
1
2017
476
0.030
 Why?
Induction Chemotherapy
1
2014
60
0.030
 Why?
Matrix Metalloproteinase 2
2
2006
57
0.030
 Why?
Receptor, Platelet-Derived Growth Factor beta
1
2013
20
0.030
 Why?
Depression
1
2019
570
0.030
 Why?
Proto-Oncogene Proteins c-kit
1
2013
36
0.030
 Why?
Melphalan
1
2014
174
0.030
 Why?
Statistics as Topic
1
2013
87
0.030
 Why?
Cancer Care Facilities
1
2013
20
0.030
 Why?
Time
1
2013
25
0.030
 Why?
Administration, Cutaneous
1
2013
53
0.030
 Why?
Infusions, Intravenous
1
2013
213
0.030
 Why?
Specialization
1
2013
46
0.030
 Why?
Molecular Targeted Therapy
1
2013
121
0.030
 Why?
Gene Expression Regulation
1
2017
979
0.030
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2013
55
0.030
 Why?
Demography
1
2013
92
0.030
 Why?
Antitrichomonal Agents
1
2012
1
0.030
 Why?
Risk Assessment
1
2017
1262
0.030
 Why?
Combined Modality Therapy
1
2014
636
0.030
 Why?
Reference Values
1
2013
310
0.030
 Why?
Polyethylene Glycols
1
2012
93
0.030
 Why?
Medical Oncology
1
2013
95
0.030
 Why?
Antigens, Viral
1
2012
44
0.030
 Why?
Administration, Topical
1
2011
56
0.020
 Why?
Single-Blind Method
1
2011
115
0.020
 Why?
Sex Factors
1
2013
697
0.020
 Why?
Neoplasm Proteins
1
2013
324
0.020
 Why?
Organ Size
1
2011
225
0.020
 Why?
Retrospective Studies
1
2022
6134
0.020
 Why?
Antibodies, Viral
1
2010
88
0.020
 Why?
Survival Rate
1
2012
901
0.020
 Why?
Anti-Retroviral Agents
1
2008
14
0.020
 Why?
Psychiatric Status Rating Scales
1
2009
319
0.020
 Why?
Psychometrics
1
2009
224
0.020
 Why?
Lectins
1
2007
14
0.020
 Why?
Busulfan
1
2008
19
0.020
 Why?
Mutation
1
2013
1294
0.020
 Why?
Glycosylation
1
2007
101
0.020
 Why?
Mice
1
2017
5759
0.020
 Why?
Ultrasonography
1
2008
437
0.020
 Why?
Maximum Tolerated Dose
1
2006
37
0.020
 Why?
Injections, Subcutaneous
1
2006
54
0.020
 Why?
Hypertension, Renal
1
2005
22
0.020
 Why?
Cell Proliferation
1
2009
1013
0.020
 Why?
Fatigue
1
2006
117
0.020
 Why?
Pyridoxine
1
2004
4
0.020
 Why?
Ribonucleotides
1
2004
5
0.020
 Why?
Vitamin B 12
1
2004
27
0.020
 Why?
Erythrocytes
1
2004
83
0.010
 Why?
Recombinant Proteins
1
2006
487
0.010
 Why?
Adenosine
1
2004
70
0.010
 Why?
Homocysteine
1
2004
128
0.010
 Why?
Receptors, Interleukin-6
1
2002
22
0.010
 Why?
Endothelial Growth Factors
1
2002
9
0.010
 Why?
Vascular Endothelial Growth Factors
1
2002
15
0.010
 Why?
Lymphokines
1
2002
20
0.010
 Why?
Drug Tolerance
1
2002
60
0.010
 Why?
Safety
1
2002
77
0.010
 Why?
Child, Preschool
1
2005
3883
0.010
 Why?
Lee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (464) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (28) people
_
Same Department Expand Description
Search Department